Dr Luke Tattersall

All publications

Journal articles

• Coleman JC, Tattersall L, Yianni V, Knight L, Yu H, Hallett S, Johnson P, Caetano A, Cosstick C, Ridley A , Gartland A et al (2024) The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis. iScience, 109288-109288.
• Green D, Singh A, Tippett VL, Tattersall L, Shah KM, Siachisumo C, Ward NJ, Thomas P, Carter S, Jeys L , Sumathi V et al (2023) YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522. Journal of Bone Oncology, 39, 100474-100474.
• Tattersall L, Gagui DC, Tippett VL, Latif NBA, Shah KM & Gartland A (2022) A systematic review of the expression, signalling and function of P2 receptors in primary bone cancer. Frontiers in Bioscience-Landmark, 27(4). View this article in WRRO
• Tattersall L, Shah KM, Lath DL, Singh A, Down JM, De Marchi E, Williamson A, Di Virgilio F, Heymann D, Adinolfi E , Fraser WD et al (2021) The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties. Journal of Bone Oncology, 31. View this article in WRRO
• Tattersall L, Adinolfi E, Antonioli L & Agrawal A () Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting report. Purinergic Signalling.
• Tattersall L, Agrawal A, Adinolfi E & Gartland A () EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report. Purinergic Signalling.
• Tippett VL, Tattersall L, Ab Latif NB, Shah KM, Lawson MA & Gartland A () The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. Oncogene.

Chapters

• Tattersall L, Davison Z & Gartland A (2020) Osteosarcoma, Encyclopedia of Bone Biology (pp. 362-378). Elsevier

Conference proceedings papers

• Tattersall L, De Marchi E, Williamson A, Di VF, Lawson MA, Adinolfi E & Gartland A (2018) P2X7R in primary bone cancer. PURINERGIC SIGNALLING, Vol. 14 (pp S13-S14)

Website content

• Tattersall L & Shah K Culture of MLO-A5 and MLO-Y4 osteocyte cell lines.

Preprints

• Coleman JC, Tattersall L, Yianni V, Knight L, Yu H, Hallett S, Johnson P, Caetano A, Cosstick C, Ridley A , Gartland A et al (2023) The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis, Cold Spring Harbor Laboratory.
• Shah KM, Tattersall L, Hussain A, Macfarlane SC, Williamson A, Acosta-Martin AE, Erler JT, Ottewell PD & Gartland A () P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasis, Cold Spring Harbor Laboratory.
• Tattersall L, Shah KM, Lath DL, Singh A, Down JM, De Marchi E, Williamson A, Di Virgilio F, Heymann D, Adinolfi E , Fraser WD et al () The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties, Cold Spring Harbor Laboratory.